Summary
- Current Price
- As of today, AVDL price is $21.64, unchanged in the most recent trading session on
- Current Price All-Time High
- AVDL price is currently -50.37% below its historical high of $43.60 set on
- Market Cap
- AVDL current market cap is $2B, up +144.79% over the past 365 days
- PE Ratio
- AVDL PE ratio is unknown
- Revenue
- AVDL current annual revenue is $169.12M, up +504.79% year-over-year
- Next Earnings
- The next earnings release for AVDL is on
Profile
| Metric | Value |
|---|---|
| Full Name | Avadel Pharmaceuticals plc |
| Ticker | NASDAQ: AVDL |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | Ireland |
| IPO | |
| Indexes | Not included |
| Website | avadel.com |
| Employees | 188 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $21.64 | |
| Price, 1D Change | 0.00% | |
| $2B | ||
| - | ||
| - | ||
| 0.67 | ||
| $169M | ||
| Revenue, 1Y Change | +504.79% | |
| -$0.51 | ||
| EPS, 1Y Change | +74.32% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | FLML | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.51 | ||
| EPS Estimate | $0.21 | |
| EPS Est. Change | +140.64% | |
| $169.12M | ||
| Revenue Estimate | $277.42M | |
| Revenue Est. Change | +64.04% | |
| Current Price | $21.64 | |
| Price Target | - | $20.00 |
| Price Tgt. Change | - | -7.58% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.83 | -$2.00 | -9.24% | |
| -$0.49 | -$0.51 | -3.93% | |
| $0.21 | N/A | +140.64% | |
| $0.78 | N/A | +251.96% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $27.96M | $27.96M | 0.00% | |
| $168.74M | $169.12M | +0.23% | |
| $277.42M | N/A | +64.04% | |
| $360.28M | N/A | +113.04% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $21.64 | |
| $15.56 | ||
| SMA 200 vs Price | -28.12% | |
| $21.51 | ||
| SMA 50 vs Price | -0.61% | |
| 0.67 | ||
| $0.08 | ||
| 61.51 | ||
| 2.89% | ||
| 47.48% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $169.12M | ||
| -$0.51 | ||
| $153.84M | ||
| 90.97% | ||
| -$42.40M | ||
| -25.07% | ||
| -$48.83M | ||
| -28.87% | ||
| -$35.57M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 2.75 | ||
| 2.33 | ||
| - | ||
| 4 | ||
| 3.00 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 8.55 | ||
| 21.62 | ||
| 252.45 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $73.85M | ||
| $51.37M | ||
| $265.80M | ||
| $134.21M | ||
| $191.95M | ||
| $48.83M | ||
| $36.95M | ||
| $582.00K | ||
| $7.33M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $211.52M | ||
| $196.24M | ||
| $15.28M | ||
| $181.04M | ||
| $2.68M | ||
| $0.00 | ||
| -$247.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$46.91M | ||
| $51.78M | ||
| $15.97M | ||
| $0.00 | ||
| -$46.91M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wells Fargo | → | |
| Wells Fargo | → | |
| UBS | → | |
| Leerink Partners | → | |
| HC Wainwright & Co. | → | |
| Needham | → | |
| Jefferies | → | |
| HC Wainwright & Co. | → | |
| Wells Fargo | ||
| UBS | → |
Analyst sentiment
Institutional ownership
Screeners with AVDL
FAQ
What is the ticker symbol for Avadel Pharmaceuticals plc?
The ticker symbol for Avadel Pharmaceuticals plc is NASDAQ:AVDL
Does Avadel Pharmaceuticals plc pay dividends?
No, Avadel Pharmaceuticals plc does not pay dividends
What sector is Avadel Pharmaceuticals plc in?
Avadel Pharmaceuticals plc is in the Healthcare sector
What industry is Avadel Pharmaceuticals plc in?
Avadel Pharmaceuticals plc is in the Specialty & Generic Drug Manufacturers industry
What country is Avadel Pharmaceuticals plc based in?
Avadel Pharmaceuticals plc is headquartered in Ireland
When did Avadel Pharmaceuticals plc go public?
Avadel Pharmaceuticals plc initial public offering (IPO) was on June 7, 1996
Is Avadel Pharmaceuticals plc in the S&P 500?
No, Avadel Pharmaceuticals plc is not included in the S&P 500 index
Is Avadel Pharmaceuticals plc in the NASDAQ 100?
No, Avadel Pharmaceuticals plc is not included in the NASDAQ 100 index
Is Avadel Pharmaceuticals plc in the Dow Jones?
No, Avadel Pharmaceuticals plc is not included in the Dow Jones index
When was Avadel Pharmaceuticals plc last earnings report?
Avadel Pharmaceuticals plc's most recent earnings report was on November 4, 2025
When does Avadel Pharmaceuticals plc report earnings?
The next expected earnings date for Avadel Pharmaceuticals plc is March 2, 2026
Data Sources & References
- AVDL Official Website www.avadel.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1012477/000101247725000031/0001012477-25-000031-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1012477/000101247725000010/0001012477-25-000010-index.htm
- AVDL Profile on Yahoo Finance finance.yahoo.com/quote/AVDL
- AVDL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/avdl
